These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
170 related articles for article (PubMed ID: 34487462)
1. Detection of a novel antigen for Crohn's disease. Wei Y; Chen T; Yang W; Li H; Fang C; Liu Q; Chen Y; Mei Q Scand J Gastroenterol; 2021 Dec; 56(12):1427-1433. PubMed ID: 34487462 [TBL] [Abstract][Full Text] [Related]
2. Serologic testing with ANCA, ASCA, and anti-OmpC in children and young adults with Crohn's disease and ulcerative colitis: diagnostic value and correlation with disease phenotype. Zholudev A; Zurakowski D; Young W; Leichtner A; Bousvaros A Am J Gastroenterol; 2004 Nov; 99(11):2235-41. PubMed ID: 15555007 [TBL] [Abstract][Full Text] [Related]
3. Diagnostic utility, disease activity, and disease phenotype correlation of serum ASCA, pANCA, and PR3-ANCA in pediatric inflammatory bowel disease. Kim JM; Choi YM; Jung SA; Yang HR J Pediatr (Rio J); 2024; 100(2):204-211. PubMed ID: 38012956 [TBL] [Abstract][Full Text] [Related]
4. Diagnostic value of anti-Saccharomyces cerevisiae and antineutrophil cytoplasmic autoantibodies in inflammatory bowel disease. Peeters M; Joossens S; Vermeire S; Vlietinck R; Bossuyt X; Rutgeerts P Am J Gastroenterol; 2001 Mar; 96(3):730-4. PubMed ID: 11280542 [TBL] [Abstract][Full Text] [Related]
5. Diagnostic value of antineutrophil cytoplasmic antibodies and anti-Saccharomyces cerevisiae antibody in Iranian patients with inflammatory bowel disease. Bahari A; Aarabi M; Aarabi M; Hedayati M; Jarollahi A; Firouzi F; Aghazadeh R; Zali MR; Hashemi M Acta Gastroenterol Belg; 2009; 72(3):301-5. PubMed ID: 19902862 [TBL] [Abstract][Full Text] [Related]
6. Association of Anti-glycan Antibodies and Inflammatory Bowel Disease Course. Paul S; Boschetti G; Rinaudo-Gaujous M; Moreau A; Del Tedesco E; Bonneau J; Presles E; Mounsef F; Clavel L; Genin C; Flourié B; Phelip JM; Nancey S; Roblin X J Crohns Colitis; 2015 Jun; 9(6):445-51. PubMed ID: 25895876 [TBL] [Abstract][Full Text] [Related]
7. Diagnostic role and clinical correlates of anti-Saccharomyces cerevisiae antibodies (ASCA) and anti-neutrophil cytoplasmic antibodies (p-ANCA) in Italian patients with inflammatory bowel diseases. Saibeni S; Folli C; de Franchis R; Borsi G; Vecchi M Dig Liver Dis; 2003 Dec; 35(12):862-8. PubMed ID: 14703881 [TBL] [Abstract][Full Text] [Related]
8. Diagnostic precision of anti-Saccharomyces cerevisiae antibodies and perinuclear antineutrophil cytoplasmic antibodies in inflammatory bowel disease. Reese GE; Constantinides VA; Simillis C; Darzi AW; Orchard TR; Fazio VW; Tekkis PP Am J Gastroenterol; 2006 Oct; 101(10):2410-22. PubMed ID: 16952282 [TBL] [Abstract][Full Text] [Related]
9. Diagnostic accuracy of serological assays in pediatric inflammatory bowel disease. Ruemmele FM; Targan SR; Levy G; Dubinsky M; Braun J; Seidman EG Gastroenterology; 1998 Oct; 115(4):822-9. PubMed ID: 9753483 [TBL] [Abstract][Full Text] [Related]
10. [Diagnostic role of anti-saccharomyces cerevisiae and antineutrophil cytoplasmic autoantibodies in inflammatory bowel disease]. Gao X; Hu PJ; He Y; Liao SY; Peng S; Chen MH Zhonghua Nei Ke Za Zhi; 2005 Jun; 44(6):428-30. PubMed ID: 16008854 [TBL] [Abstract][Full Text] [Related]
12. [Diagnostic role of anti-Saccharomyces cerevisiae and antineutrophil cytoplasmic autoantibodies in pediatric inflammatory bowel disease]. Kim JE; Kim KS; Seo JK Korean J Gastroenterol; 2003 Oct; 42(4):297-302. PubMed ID: 14634349 [TBL] [Abstract][Full Text] [Related]
13. Anti-Saccharomyces cerevisiae mannan antibodies and antineutrophil cytoplasmic autoantibodies in Greek patients with inflammatory bowel disease. Koutroubakis IE; Petinaki E; Mouzas IA; Vlachonikolis IG; Anagnostopoulou E; Castanas E; Maniatis AN; Kouroumalis EA Am J Gastroenterol; 2001 Feb; 96(2):449-54. PubMed ID: 11232689 [TBL] [Abstract][Full Text] [Related]
14. Diagnostic role and clinical association of ASCA and ANCA in Brazilian patients with inflammatory bowel disease. Nisihara RM; de Carvalho WB; Utiyama SR; Amarante H; Baptista ML Dig Dis Sci; 2010 Aug; 55(8):2309-15. PubMed ID: 19826949 [TBL] [Abstract][Full Text] [Related]
15. A prospective comparative study of ASCA and pANCA in Chinese and Caucasian IBD patients. Lawrance IC; Murray K; Hall A; Sung JJ; Leong R Am J Gastroenterol; 2004 Nov; 99(11):2186-94. PubMed ID: 15555001 [TBL] [Abstract][Full Text] [Related]
16. Serological markers facilitate the diagnosis of Crohn's disease. Gao X; Zhang Y Postgrad Med; 2021 Apr; 133(3):286-290. PubMed ID: 33406965 [No Abstract] [Full Text] [Related]
17. [Assessment of usefulness of anti-Saccharomyces cerevisiae and anti-neutrophil cytoplasmic antibodies in patients with unspecific inflammatory bowel diseases]. Mokrowiecka A; Gasiorowska A; Małecka-Panas E Pol Merkur Lekarski; 2004; 17 Suppl 1():22-6. PubMed ID: 15603341 [TBL] [Abstract][Full Text] [Related]
18. Clinical utility of serological markers in inflammatory bowel disease. Mokrowiecka A; Daniel P; Słomka M; Majak P; Malecka-Panas E Hepatogastroenterology; 2009; 56(89):162-6. PubMed ID: 19453050 [TBL] [Abstract][Full Text] [Related]
19. Evaluation of serological markers to differentiate between ulcerative colitis and Crohn's disease: pANCA, ASCA and agglutinating antibodies to anaerobic coccoid rods. Linskens RK; Mallant-Hent RC; Groothuismink ZM; Bakker-Jonges LE; van de Merwe JP; Hooijkaas H; von Blomberg BM; Meuwissen SG Eur J Gastroenterol Hepatol; 2002 Sep; 14(9):1013-8. PubMed ID: 12352222 [TBL] [Abstract][Full Text] [Related]
20. The prevalence and diagnostic value of perinuclear antineutrophil cytoplasmic antibodies and anti-Saccharomyces cerevisiae antibodies in patients with inflammatory bowel disease in mainland China. Zhou F; Xia B; Wang F; Shrestha UK; Chen M; Wang H; Shi X; Chen Z; Li J Clin Chim Acta; 2010 Oct; 411(19-20):1461-5. PubMed ID: 20570669 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]